Blog - Page 2 of 5598 - QualityStocks

MondayApr 06, 2026 9:10 am

QualityStocksNewsBreaks – Frontieras North America Marks Mason County Plant Groundbreaking With Ceremony in West Virginia

Frontieras North America held a groundbreaking ceremony in Point Pleasant, West Virginia, to mark the start of construction on its Mason County Plant, the company’s first commercial-scale facility utilizing its proprietary FASForm coal processing technology. Executives and local officials emphasized the project’s role in transforming coal into higher-value outputs, including ultra-low sulfur diesel, fertilizers and advanced carbon materials, through a closed-loop system designed to eliminate emissions and waste. Company leadership outlined expectations for significant economic impact, including hundreds of permanent jobs and thousands of construction roles during the buildout phase. The event brought together stakeholders from across industry and government,…

MondayApr 06, 2026 9:00 am

QualityStocksNewsBreaks – Datavault AI Inc. (NASDAQ: DVLT) to Showcase RWA Tokenization Technologies at XRP Tokyo 2026

Datavault AI (NASDAQ: DVLT) announced that CEO Nathaniel T. Bradley will present and exhibit the Company’s DataValue(R), DataScore(R), Data Vault Bank(R) AI Agent and Information Data Exchange(R) technologies at XRP Tokyo 2026 on April 7, 2026, highlighting its AI-powered infrastructure for real-world asset tokenization as it targets Japan’s rapidly expanding, regulation-friendly market and broader APAC growth opportunities. To view the full press release, visit https://ibn.fm/Ut57Z About Datavault AI Datavault AI(TM) (Nasdaq:DVLT) leads AI-driven data experiences, valuation, and monetization in the Web 3.0 environment. The Company's cloud-based platform delivers comprehensive solutions through its collaborative Acoustic Science and Data Science Divisions. Datavault…

MondayApr 06, 2026 9:00 am

MindBio Therapeutics Corp. (CSE: MBIO) (OTCQB: MBQIF) Targets South American Mining Sector as Voice-Based Drug and Alcohol Impairment Screening Platform Moves Toward Commercial Deployment

Disseminated on behalf of MindBio Therapeutics Corp. (CSE: MBIO) (OTCQB: MBQIF)and may include paid advertising. The company has appointed Chilean drug policy specialist Felipe Leyton to lead commercialization in South America’s mining industry. The company is preparing to deploy its voice-based AI drug and alcohol impairment detection platform in industrial environments beginning in 2026, with Chile’s mining sector, employing more than 200,000 workers, representing an early target market. MindBio’s technology analyzes voice patterns to detect intoxication or impairment without biological testing, and management is positioning the platform as a scalable tool for workplace safety in mining and other high-risk industries.…

ThursdayApr 02, 2026 11:07 am

QualityStocksNewsBreaks – Xeriant, Inc. (OTCQB: XERI) Notice Of Allowance For Fire-Resistant Composite Patent

Xeriant (OTCQB: XERI) announced the U.S. Patent and Trademark Office has issued a Notice of Allowance for its patent covering a proprietary multilayered fire-resistant composite and manufacturing method, marking a key milestone for its DUREVER(TM) materials platform. The technology, featured in NEXBOARD(TM) composite wallboard, is advancing toward certification testing and is designed to deliver enhanced fire resistance, strength and sustainability across multiple industries, while the company also pursues international patent protection and expands its intellectual property and branding strategy. To view the full press release, visit https://ibn.fm/TG0Pf About Xeriant, Inc. Xeriant, Inc. is dedicated to the discovery, development and commercialization of transformative technologies, including advanced materials, which can be successfully integrated and deployed…

ThursdayApr 02, 2026 10:57 am

QualityStocksNewsBreaks – Soligenix Inc. (NASDAQ: SNGX) Publishes Positive HyBryte Study Results In Oncology and Therapy

Soligenix (NASDAQ: SNGX) announced the publication of positive results from its comparability study evaluating HyBryte(TM) versus Valchlor(R) for the treatment of cutaneous T-cell lymphoma in Oncology and Therapy, highlighting favorable efficacy and safety outcomes. After 12 weeks, 60% of HyBryte-treated patients achieved treatment success compared to 20% for Valchlor, with greater average improvement and no treatment-related adverse events reported for HyBryte, while Valchlor patients experienced multiple adverse reactions, supporting HyBryte’s potential as a well-tolerated therapy for early-stage CTCL. To view the full press release, visit https://ibn.fm/YchgE About Soligenix Soligenix is a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need. Our Specialized BioTherapeutics business segment is developing and…

ThursdayApr 02, 2026 10:43 am

QualityStocksNewsBreaks – MAX Power Mining Corp. (CSE: MAXX; OTC: MAXXF; FRANKFURT: 89N) Expands Saskatchewan Natural Hydrogen Portfolio with New Discovery Milestones

This article has been disseminated on behalf of MAX Power Mining and may include paid advertising. MAX Power Mining (CSE: MAXX; OTC: MAXXF; FRANKFURT: 89N) reported a series of milestones advancing the scale and commercial potential of its Saskatchewan-based Natural Hydrogen portfolio, including successful drilling at the Bracken Well, completion of a high-resolution 3D seismic survey at the Lawson Discovery and surrounding area, and identification of a new Lawson-style target 12 km southwest of the original discovery. Backed by a recent $20.5 million financing, the company is accelerating efforts to position Saskatchewan as a hub for Natural Hydrogen commercialization, with upcoming catalysts including follow-up drilling, testing at…

ThursdayApr 02, 2026 10:32 am

QualityStocksNewsBreaks – NurExone Biologic Inc. (TSX.V: NRX) (OTCQB: NRXBF) (FSE: J90) Wins BOLD Awards VII Healthcare Honor, Engages IBN For Investor Outreach

This article has been disseminated on behalf of NurExone Biologic and may include paid advertising. NurExone Biologic (TSX.V: NRX) (OTCQB: NRXBF) (FSE: J90) announced it received first place in the Healthcare category at the BOLD Awards VII Gala held March 27, 2026, in Barcelona, recognizing its leadership in exosome-based therapies for central nervous system injuries, and also provided a corporate update highlighting its selection by a panel of global industry leaders. The company further reported plans to engage Investor Brand Network (IBN), subject to TSX Venture Exchange approval, to support investor awareness efforts beginning April 1, 2026, including distribution of news and updates across more than 5,000 outlets, with a monthly fee of $6,500 under…

ThursdayApr 02, 2026 10:00 am

QualityStocksNewsBreaks – SPARC AI Inc. (CSE: SPAI) (OTCQB: SPAIF) (Frankfurt: 5OV0) Releases Updated Investor Presentation Highlighting Growth Strategy

This article has been disseminated on behalf of SPARC AI Inc. and may include paid advertising. SPARC AI (CSE: SPAI) (OTCQB: SPAIF) (Frankfurt: 5OV0) announced the release of its latest investor presentation, outlining strategy, technology development and commercial growth initiatives, including expanded global distribution efforts for its Overwatch solution. The platform delivers advanced targeting, geolocation and navigation capabilities in GPS-denied or degraded environments, with the company advancing discussions with potential partners and customers across multiple jurisdictions. To view the full press release, visit https://ibn.fm/B4qJW About SPARC AI Inc. SPARC AI is a defence technology company solving one of the most…

ThursdayApr 02, 2026 9:50 am

QualityStocksNewsBreaks – Oncotelic Therapeutics, Inc. (OTCQB: OTLC) Partners with TechForce Robotics to Advance AI-Enabled GMP Automation Platform

Oncotelic Therapeutics (OTCQB: OTLC) announced a strategic partnership with TechForce Robotics to advance commercialization of its PDAOAI-enabled, GMP-compliant robotics platform designed for pharmaceutical manufacturing and regulated environments. The integrated system combines Oncotelic’s proprietary AI capabilities with TechForce’s robotics and manufacturing expertise to enable automated material handling, real-time monitoring and compliance workflows, with scalability for broader deployment, as the companies move forward under a joint development, manufacturing and licensing agreement to address growing demand for intelligent, compliant automation solutions. To view the full press release, visit https://ibn.fm/nvCXn About Oncotelic Therapeutics Oncotelic Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on the development…

ThursdayApr 02, 2026 9:45 am

Ucore Rare Metals Inc. (TSX.V: UCU) (OTCQX: UURAF) Strengthens Position amid Global REE Supply Challenges

Disseminated on behalf of Ucore Rare Metals Inc. (TSX.V: UCU) (OTCQX: UURAF) and may include paid advertising. Industry analysts project that REEs used in clean-energy technologies could see demand increase two to three times by 2040. Despite the importance of these precious elements, global supply chains for REEs remain highly concentrated. Ucore is developing technologies and facilities designed to process rare earth concentrates into high-purity oxides that can be used in manufacturing. Rare earth elements have become one of the most strategically important groups of materials in the modern global economy, underpinning technologies that range from electric vehicles to advanced…

Site Search

Company Search